Explore the detailed record of transactions filed by PARMAR KUSH, Director. Insider active across 3 companies, notably Rallybio Corp. In total, 10 disclosures have been recorded. Total volume traded: €11.6m. The latest transaction was filed on 3 June 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Kush Parmar is a Board Member at Rallybio Corp, Entrada Therapeutics, Inc., and Vor Biopharma Inc. He contributes to corporate governance and oversight of operations. Kush is involved in strategic decisions that influence the performance of these companies.